Thanks ohm. Would like to emphasize that after 12 months those women treated with Leronlimab haven't even reached mOS yet. Just in case somebody misinterprets it and says, hey Leronlimab reached 12 compared to the typical 6 - 7 months. Time is still ticking until 50% is hit.

Quote:
"This result is even more amazing as these women did not even reach mOS in 12 months, considering the typical mOS in this population is only 6 to 7 months.”